Migraine and triptan therapy in an aging population: weighing risks against benefits

The Behavioral Voice-Lift

ASHA Leader ◽

10.1044/leader.ftr4.18032013.np ◽

2013 ◽

Vol 18 (3) ◽

Author(s):

Aaron Ziegler ◽

Edie Hapner

Keyword(s):

Aging Population

Learn how SLPs can help restore the youthful voice of an aging population.

Download Full-text

521: Oral Desmopressin in the Treatment of Nocturia in Aging Population

The Journal of Urology ◽

10.1016/s0022-5347(18)37783-8 ◽

2004 ◽

Vol 171 (4S) ◽

pp. 139-139

Author(s):

Aksam A. Yassin ◽

Fadi Schukfeh

Keyword(s):

Aging Population

Download Full-text

Refining Evidence-Based Treatments for Late-Life Depression

GeroPsych ◽

10.1024/1662-9647/a000127 ◽

2015 ◽

Vol 28 (2) ◽

pp. 67-76

Author(s):

Grace C. Niu ◽

Patricia A. Arean

Keyword(s):

Older Adults ◽

Mental Illness ◽

Brain Plasticity ◽

Late Life ◽

Aging Population ◽

The United States ◽

Future Research ◽

Evidence Based ◽

Late Life Depression ◽

Evidence Based Treatments

The recent increase in the aging population, specifically in the United States, has raised concerns regarding treatment for mental illness among older adults. Late-life depression (LLD) is a complex condition that has become widespread among the aging population. Despite the availability of behavioral interventions and psychotherapies, few depressed older adults actually receive treatment. In this paper we review the research on refining treatments for LLD. We first identify evidence-based treatments (EBTs) for LLD and the problems associated with efficacy and dissemination, then review approaches to conceptualizing mental illness, specifically concepts related to brain plasticity and the Research Domain Criteria (RDoc). Finally, we introduce ENGAGE as a streamlined treatment for LLD and discuss implications for future research.

Download Full-text